Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Ōbu
Clinical trial register · Japan

Clinical Trials in Ōbu, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2517 matching records held by the registry are in this view. Synced 15 Nov 2026, 03:19 UTC
2517
Studies in scope
all four open statuses
1288
Recruiting now
open to new participants
355
Lead sponsors
across recruiting studies
Top sites
Bunkyō City 7 Ōbu 7 Osaka 3 Chūōku 3 Hadano 3
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Eli Lilly and Company7
Target enrolment
to

Trials with a site in Ōbu

7 of 2517 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Not yet open
A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)
NCT07843459Healthy Volunteers, Alzheimer Disease, Amyloid, Plaque, Amyloid
Eli Lilly and Company
Phase 1
111
Bunkyō City, Ōbu
2026-10
Recruiting
Eli Lilly and Company
Phase 1
179
Bunkyō City, Ōbu
2026-09-09
Recruiting
Eli Lilly and Company
Phase 3
550
Chūōku, Hachiōji, Ōbu, Shinjuku, Shinjyuku, tabashi City
2026-05-22
Recruiting
A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease
NCT07787182Healthy Volunteers, Alzheimer Disease, Amyloid, Plaque, Amyloid
Eli Lilly and Company
Phase 1
68
Bunkyō City, Ōbu
2025-10-14
Recruiting
Eli Lilly and Company
Phase 1
128
Bunkyō City, Ōbu
2024-10-29
Active, closed
Eli Lilly and Company
Phase 3
2,996
Bunkyō City, Chūōku, Hachiōji, Osaka, Ōbu, Shinjuku, Shinjuku-ku, Suita-shi
2021-08-27
Active, closed
Eli Lilly and Company
Phase 3
1,736
Nagoya, Ōbu, Inage, Akashi, Himeji, Kobe, Inashiki, Toride
2020-06-19
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 November 2026. https://priyalifescience.com/clinical-trials-japan/city/bu

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,517 studies in total at the last sync on 15 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies with a site in Ōbu that also match the filters currently applied.

How many clinical trials are recruiting in Ōbu?

4 of the 7 studies on this page are recruiting new participants as of the 15 Nov 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ōbu), 7 studies
PhaseStudiesRecruitingShare
Phase 14357.1%
Phase 33142.9%

Most active sponsors

Lead sponsors with the most studies (Ōbu)
Lead sponsorStudiesRecruiting
Eli Lilly and Company74
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.